AMM Safety First Trust Principal-Protected Trust Certificates Linked TO The S&P 500 Index

AMS Health Sciences, Inc., (Amex:AMM), today announced a net loss for the third quarter 2005 of $513,868, or $(0.07) per common (diluted) share, on 7.5 million shares outstanding, compared to a net loss of $1,021,657, or $(0.15) per common (diluted) share, on 6.9 million shares outstanding in the third quarter of 2004. Sales totaled $2.9 million for the quarter compared to sales of $4.5 million for the quarter ended September 30, 2004. Cash, Marketable Securities and Trade Receivables at September 30, 2005 totaled $1.7 million compared to $3.6 million at December 31, 2004. The quick ratio of assets to liabilities was approximately 2:1, compared to 3:1 at December 31, 2004, while shareholders' equity at September 30, 2005 was $3.4 million compared to shareholders' equity of $6.8 million at December 31, 2004. Sales for the first nine months of 2005 totaled $10.4 million compared to $13.3 million for the same period in 2004. Net loss for the first nine months of 2005 was $2,621,737, or ($0.36) per common (diluted) share, on 7.2 million shares outstanding, compared to a net loss of $1,909,963, or ($0.28) per common (diluted) share, on 6.7 million shares outstanding, in the year 2004. AMS Health Sciences, Inc., sells more than 60 natural nutritional supplements, weight management products, and natural skincare products through independent distributors across the U.S. and Canada. More information about the Company is available at http://www.amsonline.com